Maven Securities’s Electra Therapeutics, Inc. Common stock ETRA Stock Holding History

Maven Securities’s Portfolio ETRA Stock Details ETRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.25M	Buy	+200,000	New	+$2.46M	0.03%	228

Other funds holding ETRA

EQT Fund Management Luxembourg $947M AUM 19.95% 1-Year Est. Return

Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return

Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

MIC Capital Management (UK) London, United Kingdom $463M AUM 7.9% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

Maven Securities's ETRA Position: Q3 2026 in Review

Maven Securities opened a new position in Electra Therapeutics, Inc. Common stock (ETRA) in Q3 2026: 200,000 shares worth $2.25M. The stake represents 0.03% of the portfolio and ranks #228 among its holdings.

25 funds tracked by Wall St. Rank hold ETRA as of Q3 2026.

Maven Securities held 200,000 shares of Electra Therapeutics, Inc. Common stock worth $2.25M as of Q3 2026.
Electra Therapeutics, Inc. Common stock was a new Maven Securities position in Q3 2026.
Electra Therapeutics, Inc. Common stock made up 0.03% of Maven Securities's portfolio in Q3 2026, its #228 holding.
25 funds tracked by Wall St. Rank held Electra Therapeutics, Inc. Common stock as of Q3 2026.

Based on Maven Securities's 13F filing for Q3 2026, filed 13 Nov 2026.